Conditions of tumor-associated antigens as a proper target for therapeutic antibodies against solid cancers
Since the success of rituximab and trastuzumab for treatment of non-Hodgkin’s lymphoma and breast cancer, respectively, a huge therapeutic potential of monoclonal antibodies (mAbs) was realized and development of therapeutic mAbs has been widely tried against various cancers. However, the successful...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
GN Corporation Limited
2011-01-01
|
| Series: | Journal of Stem Cells and Regenerative Medicine |
| Online Access: | http://www.pubstemcell.com/monthly/007010200003.htm |